EyeGene Inc. (KOSDAQ:185490)
South Korea · Delayed Price · Currency is KRW 1,447.00
-13.00 (-0.89%)
At close: Apr 24, 2026
EyeGene Market Cap
EyeGene has a market cap or net worth of 62.55 billion as of April 24, 2026. Its market cap has decreased by -14.92% in one year.
Market Cap
62.55B
Enterprise Value
16.65B
Revenue
3.57B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,447.00
Market Cap Chart
Since November 16, 2015, EyeGene's market cap has decreased from 131.00B to 62.55B, a decrease of -52.25%. That is a compound annual growth rate of -6.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 63.12B | -16.04% |
| Dec 30, 2025 | 75.18B | 8.64% |
| Dec 30, 2024 | 69.20B | -24.46% |
| Dec 28, 2023 | 91.61B | -15.21% |
| Dec 29, 2022 | 108.04B | -73.58% |
| Dec 30, 2021 | 408.92B | 175.32% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shaperon | 82.36B |
| Naturalendo Tech | 82.09B |
| Progen | 81.33B |
| PanGen Biotech | 81.24B |
| IMGT Co.,Ltd. | 78.32B |
| Ark Solutions | 68.91B |
| HLB Pep | 68.12B |
| Aptamer Sciences | 66.02B |